Fluorescence imaging in the second near-infrared window (NIR-II) has become a prevalent
choice owing to its appealing advantages like deep penetration depth, low …

There has been continual development of fluorescent agents, imaging systems, and their
applications over the past several decades. With the recent FDA approvals of 5 …

The surgical resection of solid tumours can be enhanced by fluorescence-guided imaging.
However, variable tumour uptake and incomplete clearance of fluorescent dyes reduces the …

The growing number of cancer patients and the limitations of traditional treatments are
forcing researchers to develop more effective treatment methods. Precision medicine with …

Surgical resection is the cornerstone of solid tumour treatment. Current techniques for
evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative …

Fluorescence lifetime (FLT) multiplexing and multispectral imaging (MSI) are both frequently
employed for in vitro and ex vivo biological studies. In vivo applications of MSI for deep …

The integrative use of light and nanoassemblies has made a profound impact in the
biomedical field for diagnosis, drug delivery, and phototherapy. Recent advances in the …

Clinical imaging-assisted oncosurgical navigation requires cancer-specific miniaturized
optical imaging probes. We report a near-infrared (NIR) Fab'-based epidermal growth factor …

In patients with head and neck cancer (HNC), surgical removal of cancerous tissue presents
the best overall survival rate. However, failure to obtain negative margins during resection …

Cancer patient selection for immunotherapy is often based on programmed death-ligand-1
(PD-L1) expression as a biomarker. PD-L1 expression is currently quantified using …